D.E. Shaw & Co’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $204K | Sell |
|
|||||
|
2024
Q2 | $958K | Sell |
|
|||||
|
2024
Q1 | $1.15M | Buy |
|
|||||
|
2023
Q4 | $855K | Buy |
|
|||||
|
2023
Q3 | $1.73M | Sell |
|
|||||
|
2023
Q2 | $2.48M | Buy |
|
|||||
|
2023
Q1 | $2.49M | Buy |
|
|||||
|
2022
Q4 | $1.61M | Buy |
|
|||||
|
2022
Q3 | $1.42M | Sell |
|
|||||
|
2022
Q2 | $4.35M | Sell |
|
|||||
|
2022
Q1 | $5.72M | Buy |
|
|||||
|
2021
Q4 | $4.62M | Sell |
|
|||||
|
2021
Q3 | $5.14M | Sell |
|
|||||
|
2021
Q2 | $5.35M | Buy |
|
|||||
|
2021
Q1 | $4.51M | Buy |
|
|||||
|
2020
Q4 | $2.75M | Buy |
|
|||||
|
2020
Q3 | $1.28M | Sell |
|
|||||
|
2020
Q2 | $3.37M | Sell |
|
|||||
|
2020
Q1 | $3.47M | Buy |
|
|||||
|
2019
Q4 | $4.29M | Sell |
|
|||||
|
2019
Q3 | $4.96M | Sell |
|
|||||
|
2019
Q2 | $6.56M | Sell |
|
|||||
|
2019
Q1 | $10.2M | Sell |
|
|||||
|
2018
Q4 | $11.5M | Buy |
|
|||||
|
2018
Q3 | $8.93M | Buy |
|
|||||
|
2018
Q2 | $6.09M | Buy |
|
|||||
|
2018
Q1 | $4.11M | Buy |
|
|||||
|
2017
Q4 | $2.21M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $650K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $213K | Buy |
|
|||||
|
2016
Q1 | – | Hold |
|
|||||
|
2015
Q4 | – | Hold |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $604K | Sell |
|
|||||
|
2015
Q1 | $1.27M | Buy |
|
|||||
|
2014
Q4 | $424K | Sell |
|
|||||
|
2014
Q3 | $447K | Buy |
|